bexarotene has been researched along with taurine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arosio, P; Chia, S; Cohen, SI; Costa, AR; Dobson, CM; Habchi, J; Joshi, P; Knowles, TP; Linse, S; Müller, MB; Nollen, EA; Perni, M; Vendruscolo, M; Yagi-Utsumi, M | 1 |
1 other study(ies) available for bexarotene and taurine
Article | Year |
---|---|
An anticancer drug suppresses the primary nucleation reaction that initiates the production of the toxic Aβ42 aggregates linked with Alzheimer's disease.
Topics: Alzheimer Disease; Amino Acid Sequence; Amyloid beta-Peptides; Animals; Animals, Genetically Modified; Antineoplastic Agents; Bexarotene; Caenorhabditis elegans; Drug Discovery; Humans; In Vitro Techniques; Kinetics; Models, Animal; Molecular Sequence Data; Peptide Fragments; Protein Multimerization; Recombinant Proteins; Taurine; Tetrahydronaphthalenes | 2016 |